Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients

被引:31
|
作者
Hatta, N
Takata, M
Takehara, K
Ohara, K
机构
[1] Kanazawa Univ, Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208640, Japan
[2] Toranomon Gen Hosp, Dept Dermatol, Tokyo, Japan
关键词
melanoma; metastasis; tyrosinase; immunohistochemistry;
D O I
10.1136/jcp.51.8.597
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To evaluate immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR) for melanoma associated antigens (MAA) in detecting occult melanoma cells in lymph nodes which were missed on routine pathology. Methods-Occult melanoma cells were sought in 436 lymph nodes from 32 patients with cutaneous melanoma of the lower extremities by immunohistochemistry using the melanoma specific antibody HMB-45. The detection sensitivity of routine histology, immunohistochemistry, and RT-PCR was also compared in 23 lymph node samples from six patients. Results-Immunohistochemistry showed that 15 of 24 patients (62.5%) who had no detectable metastasis by routine histology had at least one lymph node containing HMB-45 positive cells, mostly seen singly in the medullary sinus. No difference was found in known clinicopathological prognostic factors and recurrence rates between the two groups of patients with and without occult HMB-45 positive cells. RT-PCR analyses showed that the nested PCR for tyrosinase was more sensitive than a combination of single round PCR for five different MAA, including tyrosinase, MART-1/Melan A, Pmel-17, TRP-1, and TRP-2, detecting tyrosinase mRNA in six nodes which were negative by HMB-45 immunohistochemistry. Conclusions-Immunohistochemistry + RT-PCR is more sensitive than routine histology in detecting occult melanoma cells in lymph nodes. The nested PCR for tyrosinase should be used in future studies investigating the prognostic significance of such lymph node micrometastases.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 50 条
  • [11] Current management of regional lymph nodes in patients with melanoma
    Bartlett, Edmund K.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (08) : 1186 - 1186
  • [12] Current management of regional lymph nodes in patients with melanoma
    Bartlett, Edmund K.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (02) : 200 - 207
  • [13] The Enigma of Regional Lymph Nodes in Melanoma
    Coit, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23): : 2280 - 2281
  • [14] Metastatic melanoma to regional lymph nodes
    Reintgen, D
    Li, WG
    Stall, A
    Linn, J
    Shivers, S
    IN VIVO, 2000, 14 (01): : 213 - 220
  • [15] Characteristics of NK cells isolated from regional lymph nodes of melanoma patients
    Vuletic, A.
    Konjevic, G.
    Jovanic, I.
    Inic, M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 79 - 80
  • [16] Detection of tyrosinase mRNA by polymerase chain reaction in the sentinel lymph node and in non sentinel lymph nodes of patients with malignant melanoma.
    Lukowsky, A
    Bellmann, B
    Winter, H
    Audring, H
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 455 - 455
  • [17] Immunohistochemistry of metastatic melanoma sentinel lymph nodes: Prognostic significance of size and occult nodal metastasis
    Kurylo, DM
    Carlson, GW
    Murray, DK
    Greenlee, R
    Cohen, C
    MODERN PATHOLOGY, 2001, 14 (01) : 69A - 69A
  • [18] Rapid immunohistochemistry of sentinel lymph nodes for metastatic melanoma
    Eudy, GE
    Carlson, GW
    Murray, DR
    Waldrop, SM
    Lawson, D
    Cohen, C
    HUMAN PATHOLOGY, 2003, 34 (08) : 797 - 802
  • [19] Adenocarcinoma of the pancreas - Detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay
    Demeure, MJ
    Doffek, KM
    Komorowski, RA
    Wilson, SD
    CANCER, 1998, 83 (07) : 1328 - 1334
  • [20] Review of the Guidelines on the Management of the Regional Lymph Nodes in Patients With Melanoma
    Lange, Julie R.
    JAMA SURGERY, 2020, 155 (03) : 258 - 259